 The goal of this clinical research study is to learn if certain characteristics of DNA the genetic material in cells affects how ovarian, fallopian tube, or primary peritoneal carcinomas respond to therapy with AZD1775. Researchers also want to learn if treatment with AZD1775 affects the DNA in cancer cells. 